Skip to main content

Table 2 Rush mOIT dose escalation schedule

From: Phase 1 results of safety and tolerability in a rush oral immunotherapy protocol to multiple foods using Omalizumab

Dose of protein (mg) Interval in weeks % of increase from previous
2350 mg 2 88%
4000 mg 2 70%
5800 mg 2 45%
7600 mg 2 50%
9400 mg 2 30%
11200 mg 2 20%
14000 mg 2 25%
17500 mg 2 25%
20000 mg 2 14%